Investment
Features
FeesSafety
Academy
More
Pluang+

Kintayl Capital cuts Core Scientific stake by $9.14M in Q4, signaling shift in investment amid company transition.

Market News
22 Mar 2026
The Motley Fool
View Source
Neutral
pluang ai news

Kintayl Capital sold 495,390 shares of Core Scientific in Q4 2025, reducing its stake from 6.3% to 0.66% of assets under management, with a net position decrease of $9.14 million. The sale reflects a strategic move as Core Scientific transitions from self-mining to colocation services, focusing on more stable revenue streams despite ongoing losses and heavy infrastructure investments. Core Scientific's stock has risen 84% over the past year, outperforming the S&P 500, but the company is still in a period of operational change. Investors should note the shift towards infrastructure and long-term contracts as the company adapts to market demands.

More News (CORZ)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App